Related references
Note: Only part of the references are listed.Neglected tropical diseases: progress towards addressing the chronic pandemic
David H. Molyneux et al.
LANCET (2017)
Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases
Chonny Herrera Acevedo et al.
MOLECULES (2017)
Targeting the Cytochrome bc1 Complex of Leishmania Parasites for Discovery of Novel Drugs
Diana Ortiz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Opportunities for Integrated Control of Neglected Tropical Diseases That Affect the Skin
Daniel Engelman et al.
TRENDS IN PARASITOLOGY (2016)
Sequential Chemoimmunotherapy of Experimental Visceral Leishmaniasis Using a Single Low Dose of Liposomal Amphotericin B and a Novel DNA Vaccine Candidate
Karin Seifert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids
Juan Carlos Coa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Modulation of Th1/Th2 Immune Responses by Killed Propionibacterium acnes and Its Soluble Polysaccharide Fraction in a Type I Hypersensitivity Murine Model: Induction of Different Activation Status of Antigen-Presenting Cells
Carla Cristina Squaiella-Baptistao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
Lisa Sanderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Dynamic identification of H2 epitopes from Leishmania (Leishmania) amazonensis cysteine proteinase B with potential immune activity during murine infection
Franklin Souza-Silva et al.
JOURNAL OF MOLECULAR RECOGNITION (2014)
Use of a Recombinant Cysteine Proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of Canine Visceral Leishmaniasis
Josie Haydee Lima Ferreira et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Palladacycles as Antimicrobial Agents
A. -S.S.H. Elgazwy et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Adjuvant Effect of Killed Propionibacterium acnes on Mouse Peritoneal B-1 Lymphocytes and Their Early Phagocyte Differentiation
Juliana Sekeres Mussalem et al.
PLOS ONE (2012)
In Vitro and In Vivo Activity of a Palladacycle Complex on Leishmania (Leishmania) amazonensis
Carolina de Siqueira Paladi et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
CpG Oligodeoxynucleotide 2006 and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis
Suman Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection
Bernardo A. S. Pereira et al.
BMC IMMUNOLOGY (2011)
Immunomodulation by chemotherapeutic agents against Leishmaniasis
Piu Saha et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Plant derived therapeutics for the treatment of Leishmaniasis
Rupashree Sen et al.
PHYTOMEDICINE (2011)
Current Approaches to Discover Marine Antileishmanial Natural Products
Andre G. Tempone et al.
PLANTA MEDICA (2011)
In Vitro and In Vivo Trypanocidal Effects of the Cyclopalladated Compound 7a, a Drug Candidate for Treatment of Chagas' Disease
Alisson L. Matsuo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis
Carlos Eduardo Cardoso Fedeli et al.
EXPERIMENTAL PARASITOLOGY (2010)
Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis
Hiro Goto et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Synthesis and Characterization of a Heteroleptic Ru(II) Complex of Phenanthroline Containing Oligo-Anthracenyl Carboxylic Acid Moieties
Adewale O. Adeloye et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Neutrophils Reduce the Parasite Burden in Leishmania (Leishmania) amazonensis-Infected Macrophages
Erico Vinicius de Souza Carmo et al.
PLOS ONE (2010)
Anticancer Compounds as Leishmanicidal Drugs: Challenges in Chemotherapy and Future Perspectives
Jose Perez et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-α production, but only via TNF-α it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro
Maria Imaculada Muniz-Junqueira et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Metal compounds for the treatment of parasitic diseases
Simon P. Fricker et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis
Josie Haydee L. Ferreira et al.
VACCINE (2008)
Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis
Bernardo Acacio Santini Pereira et al.
VETERINARY PARASITOLOGY (2008)
Recent advances involving palladium (II) complexes for the cancer therapy
Antonio Carlos Favero Caires
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice:: Major NKT cell recruitment and increased cytotoxicity
R. Z. Ananias et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Adjuvant effect of the propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene
JS Mussalem et al.
MICROBIOLOGY AND IMMUNOLOGY (2006)
TGF-β-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens
RO Pinheiro et al.
MICROBES AND INFECTION (2005)
Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis
CR Alves et al.
PARASITE IMMUNOLOGY (2004)
Intranasal vaccination against cutaneous Leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK
EF Pinto et al.
INFECTION AND IMMUNITY (2004)
Miltefosine for New World cutaneous leishmaniasis
J Soto et al.
CLINICAL INFECTIOUS DISEASES (2004)
Cyclopalladated compounds as chemotherapeutic agents: Antitumor activity against a murine melanoma cell line
EG Rodrigues et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs
SL Croft et al.
TRENDS IN PARASITOLOGY (2003)
Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice
EG Braga et al.
IMMUNOLOGY LETTERS (2003)
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection
EAF Coelho et al.
INFECTION AND IMMUNITY (2003)
Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection
M Colmenares et al.
INFECTION AND IMMUNITY (2003)
Leishmania model for microbial virulence:: the relevance of parasite multiplication and pathoantigenicity
KP Chang et al.
ACTA TROPICA (2003)
Development and regulation of cell-mediated immunity in experimental leishmaniasis
P Scott
IMMUNOLOGIC RESEARCH (2003)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
CP Thakur et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Identification of a 30 kDa antigen from Leishmania (L.) chagasi amastigotes implicated in protective cellular responses in a murine model
AR Pinto et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2000)
Share Paper
